• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/25/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).
 
Event Description
The patient's husband stated that the patient received erroneous results when testing with coaguchek xs meter serial number (b)(4) on (b)(6) 2018.He provided results that were in the memory of the meter.On (b)(6) 2018 at 6:41 p.M., a sample from the patient resulted as 3.5 inr when tested on the meter.On (b)(6) 2018 at 6:44 p.M., a sample from the patient resulted as 2.3 inr when tested on the meter.On (b)(6) 2018 at 6:46 p.M., a sample from the patient resulted as 1.8 inr when tested on the meter.An additional value of 2.6 inr was provided for the value on (b)(6) 2018 at 6:44 p.M.It was asked, but it is not known if this represents an additional value or if it was provided in error.A clarification has been requested.On (b)(6) 2018 at 8:57 a.M., a sample from the patient resulted as 7.0 inr when tested on the meter.On (b)(6) 2018 at 9:02 a.M., a sample from the patient resulted as 2.6 inr when tested on the meter.The patient's husband said he lanced a different finger for the second test on (b)(6) 2018.No adverse events were alleged to have occurred with the patient.No treatment was provided to the patient based on the meter results.The patient's therapeutic range is 2.0 - 3.0.The patient is not anemic and does not have antiphospholipid antibodies.The patient does not take heparin or direct thrombin inhibitors.The patient's coumadin dosage has not changed.The patient has had no changes in medications or diet.The patient has had no illnesses, bleeding, bruising, or serious injuries.The patient's product was requested for investigation and replacement product was sent to the patient.Relevant retention test strips (lot 272163-21) were tested.For this purpose two human blood samples from marcumar donors and two internal reference meters were used.No error messages occurred.Retention samples were within specifications.The patient's meter and test strips were returned for investigation.The returned meter and test strips were tested in comparison to a retention meter and master lot strips.Two human blood samples from warfarin donors and internal reference meters were used.Donor 1 inr: 2.6 inr.Donor 2 inr: 2.6 inr.Donor 1 hct: 44%.Donor 2 hct: 54%.Testing results: donor 1: retention meter with master lot strips: 2.6 inr.Customer meter with customer strips: 2.7 inr.Donor 2: retention meter with master lot strips: 2.6 inr.Customer meter with customer strips: 2.6 inr.All inr values were within the specified maximum difference between measurements.No error messages occurred.The returned material and the retention material meet specifications.Upon review of the meter memory, the following additional erroneous results were observed: on (b)(6) 2016 at 22:12, there was a value of 4.7 inr.On (b)(6) 2016 at 22:18, there was a value of 6.0 inr.On (b)(6) 2016 at 22:40, there was a value of 2.5 inr.On (b)(6) 2016 at 13:49, there was a value of 3.1 inr.On (b)(6) 2016 at 13:51, there was a value of 2.2 inr.On (b)(6) 2017 at 17:26, there was a value of 4.1 inr.On (b)(6) 2017 at 17:32, there was a value of 2.4 inr.On (b)(6) 2018 at 10:00, there was a value of 4.7 inr.On (b)(6) 2018 at 10:13, there was a value of 2.8 inr.
 
Manufacturer Narrative
In relation to this information: "on (b)(6) 2018 at 6:44 p.M., a sample from the patient resulted as 2.3 inr when tested on the meter." for this value, the customer provided a value of 2.6 inr.The meter memory indicates a value of 2.3 inr was measured at this time and date.
 
Manufacturer Narrative
Based on the meter memory, the value on (b)(6) 2018 at 6:44 p.M was actually 2.3 inr, rather than the 2.6 inr provided by the customer and reported in the initial mdr.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key7381965
MDR Text Key104149624
Report Number1823260-2018-00956
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Patient
Type of Report Initial,Followup,Followup
Report Date 04/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/31/2019
Device Catalogue Number04625374160
Device Lot Number27216321
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/20/2018
Is the Reporter a Health Professional? No
Date Manufacturer Received03/12/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age78 YR
Patient Weight82
-
-